Pharmacokinetics of Biphasic Insulin Aspart 30 and 70 in Subjects With Type 1 Diabetes

Inclusion Criteria: * Type 1 diabetes for at least 12 months * Currently on a multiple dose insulin regimen * HbA1c maximum 12.0% * BMI (body mass index) below 35 kg/m\^2 * Able and willing to perform self-blood glucose monitoring (SBGM) Exclusion Criteria: * Treatment with insulin aspart within the last 14 days prior to this trial * The receipt of any investigational drug within the last 30 days prior to this trial * Total daily insulin dose at least 1.8 U/kg * A history of drug abuse or alcohol dependence within the last 5 years * Impaired hepatic function * Impaired renal function * Blood donation within the last nine weeks or haemoglobin below the lower reference limit according to the local laboratory * Cardiac disease * Severe, uncontrolled hypertension